To strengthen accountability measures for the safekeeping of confidential prescription information after statutorily authorized release from the database.

 

DEPARTMENT OF HEALTH

Prescription Drug Monitoring Program

RULE NOS.:RULE TITLES:

64K-1.003Accessing Database

64K-1.004Management and Operation of Database

64K-1.005Privacy of Information

PURPOSE AND EFFECT: To strengthen accountability measures for the safekeeping of confidential prescription information after statutorily authorized release from the database.

SUBJECT AREA TO BE ADDRESSED: The department will develop rules establishing procedures for acquiring both direct and indirect access to the database, procedures for revoking access to the database, standards for the denial of requests for direct and indirect access to the database, as well as any other measures related to access, database operation or database management identified during the rulemaking process as promoting the privacy of confidential prescription information after statutorily authorized release from the database.

RULEMAKING AUTHORITY: 893.055 FS.

LAW IMPLEMENTED: 893.055, F.S., 893.0551 FS.

IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE REGISTER.

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Rebecca Poston, Program Manager, Prescription Drug Monitoring program, 4052 Bald Cypress Way, Bin #C-16, Tallahassee, Florida 32399 or [e-mail]

THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS AVAILABLE AT NO CHARGE FROM THE CONTACT PERSON LISTED ABOVE.